Arbor Investment Advisors LLC lifted its stake in The Allstate Co. (NYSE:ALL – Free Report) by 22.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,097 shares of the insurance provider’s stock after purchasing an additional 749 shares during the period. Arbor Investment Advisors LLC’s holdings in Allstate were worth $777,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the stock. Northwest Investment Counselors LLC bought a new position in Allstate in the third quarter valued at approximately $28,000. Versant Capital Management Inc increased its holdings in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. acquired a new position in Allstate in the second quarter valued at about $38,000. MCF Advisors LLC boosted its holdings in Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after buying an additional 84 shares during the last quarter. Finally, First Command Advisory Services Inc. acquired a new position in shares of Allstate during the 2nd quarter worth about $58,000. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Up 0.8 %
Allstate stock traded up $1.45 during mid-day trading on Monday, reaching $189.57. The company’s stock had a trading volume of 463,276 shares, compared to its average volume of 1,531,167. The business’s 50 day simple moving average is $188.18 and its 200 day simple moving average is $174.54. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Co. has a 12 month low of $123.42 and a 12 month high of $198.79. The company has a market capitalization of $50.03 billion, a price-to-earnings ratio of 41.53, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48.
Insider Buying and Selling
In related news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. Insiders own 1.80% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on ALL shares. Raymond James increased their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. JPMorgan Chase & Co. increased their target price on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Bank of America boosted their price target on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. Evercore ISI lifted their target price on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a report on Wednesday, October 9th. Finally, Roth Mkm reissued a “buy” rating and issued a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $206.44.
Get Our Latest Stock Analysis on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- The 3 Best Fintech Stocks to Buy Now
- Inflation Risk Rising, Key Trades Investors Are Making Now
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Oil Stocks to Watch Before Earnings Come Out
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.